Insider Trading Alert - DAN, PPBI And ATHN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 13, 2015, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $377.89 to $223,379,993.30.

Highlighted Stocks Traded by Insiders:

Dana (DAN) - FREE Research Report

Filcek Rodney R, who is SVP & Chief Acctg Offic at Dana, sold 4,000 shares at $22.06 on May 13, 2015. Following this transaction, the SVP & Chief Acctg Offic owned 21,038 shares meaning that the stake was reduced by 15.98% with the 4,000-share transaction.

The shares most recently traded at $21.85, down $0.21, or 0.97% since the insider transaction. Historical insider transactions for Dana go as follows:

  • 4-Week # shares bought: 5,500
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 5,500
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 5,500
  • 24-Week # shares sold: 5,000

The average volume for Dana has been 2.0 million shares per day over the past 30 days. Dana has a market cap of $3.5 billion and is part of the consumer goods sector and automotive industry. Shares are up 0.05% year-to-date as of the close of trading on Wednesday.

Dana Holding Corporation manufactures and sells driveline, sealing, and thermal-management products for vehicle manufacturers in North America, Europe, South America, and the Asia Pacific. The stock currently has a dividend yield of 1.1%. The company has a P/E ratio of 10.3. Currently, there are 5 analysts who rate Dana a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DAN - FREE

TheStreet Quant Ratings rates Dana as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, notable return on equity, attractive valuation levels and good cash flow from operations. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Dana Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Pacific Premier Bancorp (PPBI) - FREE Research Report

Mckennon Michael L, who is Director at Pacific Premier Bancorp, bought 1,000 shares at $15.42 on May 13, 2015. Following this transaction, the Director owned 31,000 shares meaning that the stake was boosted by 3.33% with the 1,000-share transaction.

The shares most recently traded at $15.84, up $0.42, or 2.65% since the insider transaction. Historical insider transactions for Pacific Premier Bancorp go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 175,000
  • 12-Week # shares bought: 2,200
  • 12-Week # shares sold: 175,000
  • 24-Week # shares bought: 21,024
  • 24-Week # shares sold: 175,000

The average volume for Pacific Premier Bancorp has been 50,800 shares per day over the past 30 days. Pacific Premier Bancorp has a market cap of $336.0 million and is part of the financial sector and banking industry. Shares are down 9.87% year-to-date as of the close of trading on Wednesday.

Pacific Premier Bancorp, Inc. operates as the bank holding company for Pacific Premier Bank that provides banking services to professionals, real estate investors, and non-profit organizations in Southern California. The company has a P/E ratio of 17.4. Currently, there are 4 analysts who rate Pacific Premier Bancorp a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PPBI - FREE

TheStreet Quant Ratings rates Pacific Premier Bancorp as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and increase in stock price during the past year. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. Get the full Pacific Premier Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AthenaHealth (ATHN) - FREE Research Report

Orenstein Daniel H., who is SVP, GC, and Secretary at AthenaHealth, sold 2,000 shares at $116.18 on May 13, 2015. Following this transaction, the SVP, GC, and Secretary owned 28,631 shares meaning that the stake was reduced by 6.53% with the 2,000-share transaction.

The shares most recently traded at $120.00, up $3.82, or 3.18% since the insider transaction. Historical insider transactions for AthenaHealth go as follows:

  • 4-Week # shares sold: 1,115
  • 12-Week # shares sold: 4,320
  • 24-Week # shares sold: 4,820

The average volume for AthenaHealth has been 516,700 shares per day over the past 30 days. AthenaHealth has a market cap of $4.6 billion and is part of the technology sector and computer software & services industry. Shares are down 18.79% year-to-date as of the close of trading on Wednesday.

athenahealth, Inc., together with its subsidiaries, operates as a business services company that provides ongoing billing, clinical-related, and other related services to medical group practices and health systems in the United States. Currently, there are 14 analysts who rate AthenaHealth a buy, 1 analyst rates it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATHN - FREE

TheStreet Quant Ratings rates AthenaHealth as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and feeble growth in the company's earnings per share. Get the full AthenaHealth Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers